{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T22:40:02Z","timestamp":1792881602573,"version":"4.5.0"},"reference-count":16,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2005,8,11]],"date-time":"2005-08-11T00:00:00Z","timestamp":1123718400000},"content-version":"vor","delay-in-days":10,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aliment Pharmacol Ther"],"published-print":{"date-parts":[[2005,8]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p><jats:bold>Aim:\u2002<\/jats:bold> To validate the gastrointestinal symptom score as an outcome measure for functional dyspepsia.<\/jats:p><jats:p><jats:bold>Methods:\u2002<\/jats:bold> In focus groups, 10 dyspepsia\u2010specific items including nausea, sickness, vomiting, bloating, abdominal cramps, early satiety, acidic eructation\/heartburn, loss of appetite, retrosternal discomfort, epigastric pain\/upper abdominal pain were identified. Ninety\u2010five patients with functional dyspepsia and 56 healthy controls were recruited and responsiveness evaluated by analysing gastrointestinal symptom score data from 357 patients from previous placebo\u2010controlled trials. Gastrointestinal symptom score response data were correlated with the patient's global assessments of efficacy. Convergent validity was assessed by correlating the gastrointestinal symptom score with the results obtained by the Nepean Dyspepsia Index.<\/jats:p><jats:p><jats:bold>Results:\u2002<\/jats:bold>  <jats:italic>Sensitivity:<\/jats:italic> In patients and healthy controls gastrointestinal symptom score yielded consistently different scores (all <jats:italic>P<\/jats:italic>\u2003&lt;\u20030.0001). <jats:italic>Test\u2013retest reliability:<\/jats:italic> Gastrointestinal symptom score determined at the two time points were significantly correlated (<jats:italic>r<\/jats:italic>\u2010values ranging from 0.842 to 0.901). <jats:italic>Convergence validity:<\/jats:italic> Gastrointestinal symptom score of both rating groups were significantly correlated with the symptom\u2010specific component of the Nepean Dyspepsia Index (<jats:italic>r<\/jats:italic>\u2010vales ranging from 0.666 to 0.764, <jats:italic>P<\/jats:italic>\u2003&lt;\u20030.01). <jats:italic>Responsiveness:<\/jats:italic> Responses of gastrointestinal symptom score during treatment were different for patients with a global self assessment as responders compared with non\u2010responders (all <jats:italic>P<\/jats:italic>\u2003&lt;\u20030.0055).<\/jats:p><jats:p><jats:bold>Conclusion:\u2002<\/jats:bold> The gastrointestinal symptom score is a valid and reliable instrument to assess symptom intensities in patients with functional dyspepsia.<\/jats:p>","DOI":"10.1111\/j.1365-2036.2005.02572.x","type":"journal-article","created":{"date-parts":[[2005,8,11]],"date-time":"2005-08-11T12:53:45Z","timestamp":1123764825000},"page":"357-363","source":"Crossref","is-referenced-by-count":87,"title":["Validation of the gastrointestinal symptom score for the assessment of symptoms in patients with functional dyspepsia"],"prefix":"10.1111","volume":"22","author":[{"given":"B.","family":"ADAM","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"LIEBREGTS","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"SAADAT\u2010GILANI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"VINSON","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"HOLTMANN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2005,8,11]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(98)70542-6"},{"key":"e_1_2_6_3_2","first-page":"II37","volume-title":"Gut","author":"Talley NJ","year":"1999"},{"key":"e_1_2_6_4_2","first-page":"660","article-title":"Drug treatment of functional dyspepsia: a systematic analysis of trial methodology with recommendations for design of future trials","volume":"91","author":"Van Zanten SJOV","year":"1996","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"e_1_2_6_5_2","first-page":"69","article-title":"Design of treatment trials for functional gastrointestinal disorders","volume":"45","author":"Veldhuyzen van Zanten SJ","year":"1999","journal-title":"Gut"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1159\/000076546"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2002-32130"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2001-16142"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2004.02275.x"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1999.00445.x"},{"key":"e_1_2_6_11_2","first-page":"106","article-title":"Validation of seven graded diary cards for severity of dyspeptic symptoms in patients with non ulcer dyspepsia","volume":"583","author":"Junghard O","year":"1998","journal-title":"Eur J Surg Suppl"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1005558204440"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(95)90373-9"},{"key":"e_1_2_6_14_2","first-page":"954","article-title":"Functional dyspepsia and irritable bowel syndrome: is there a common pathophysiological basis","volume":"92","author":"Holtmann G","year":"1997","journal-title":"Am J Gastroenterol"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004836-200203000-00004"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1053\/gast.1996.v110.pm8612991"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000441-200401000-00001"}],"container-title":["Alimentary Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2036.2005.02572.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2036.2005.02572.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T21:14:04Z","timestamp":1697231644000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2036.2005.02572.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,8]]},"references-count":16,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2005,8]]}},"alternative-id":["10.1111\/j.1365-2036.2005.02572.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2036.2005.02572.x","archive":["Portico"],"relation":{},"ISSN":["0269-2813","1365-2036"],"issn-type":[{"value":"0269-2813","type":"print"},{"value":"1365-2036","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,8]]}}}